相关实验视频
Updated: Jul 11, 2025

08:41
Modeling Chemotherapy Resistant Leukemia In Vitro
Published on: February 9, 2016
9.1K
CALM3影响白血病和的预后
Jie He1, Zhijie Ni, Zhongbo Li
1Department of Colorectal Surgery, China Aerospace Science and Industry Corporation 731 Hospital, Beijing, China.
Medicine
|November 7, 2023
概括
该研究确定CALM3是白血病和的关键基因,其表达水平与两种疾病的疾病严重程度和预后相关.
科学领域:
- 在瘤学瘤学.
- 胃肠病学 胃肠病学
- 分子生物学分子生物学
背景情况:
- 白血病涉及异常的白细胞增殖,而是胀的直肠静脉.
- 目前尚不清楚CALM3,白血病和之间的特定分子联系.
研究的目的:
- 为了研究CALM3在白血病和的发病过程中的作用.
- 通过生物信息学分析识别与这些疾病相关的关键基因和途径.
主要方法:
- 在GEO数据集 (GSE154650,GSE26294) 上进行差异基因表达分析 (limma).
- 权重基因共同表达网络分析 (WGCNA).
- 蛋白与蛋白相互作用 (PPI) 网络构建,功能丰富 (GO,KEGG),GSEA和CTD分析.
- miRNA目标预测 (TargetScan) 和西方斑点验证.
主要成果:
- 确定了125个差异表达基因 (DEGs),这些基因在小分子代谢和化学受体结合等途径中得到丰富.
- 确定了六个核心基因,包括CALM3,ACE2和PPARGC1A.
- CALM3在中表达高,在白血病中表达低,表达水平与这两种疾病的预后相关.
- 免疫透分析显示T细胞种群的变化.
结论:
- 在和白血病中,CALM3可能是关键的调节基因.
- CALM3表达水平是白血病和的潜在预后生物标志物.
- 对CALM3的监管机制进行进一步研究是有必要的.
相关概念视频
Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
Stem Cell Therapy for Tissue Regeneration
4.1K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.1K
Disorders of Leukocytes
963
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
963
Drugs for Treatment of Diarrhea-Predominant IBS
186
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
186

